关键词: Arginase-1 Cyclin-dependent protein kinase Interleukin-4 Macrophage p38 mitogen-activated protein kinase

Mesh : Animals Arginase / metabolism antagonists & inhibitors STAT6 Transcription Factor / metabolism Mice p38 Mitogen-Activated Protein Kinases / metabolism antagonists & inhibitors RAW 264.7 Cells Cyclin-Dependent Kinases / antagonists & inhibitors metabolism Interleukin-4 / metabolism Cyclin-Dependent Kinase 8 / antagonists & inhibitors metabolism Protein Kinase Inhibitors / pharmacology Macrophages / drug effects metabolism Phosphorylation / drug effects Macrophages, Peritoneal / drug effects metabolism Enzyme Activation / drug effects Flavonoids Piperidines Cyclin-Dependent Kinase 9

来  源:   DOI:10.1016/j.ejphar.2024.176852

Abstract:
Macrophages polarize into alternatively activated M2 macrophages through interleukin (IL)-4, and they express high levels of arginase-1, which promotes anti-inflammatory responses. Several studies have confirmed the anti-inflammatory effects of cyclin-dependent kinase (CDK) 8/19 inhibition, and hence, numerous CDK8/19 inhibitors, such as BRD6989, have been developed. However, the effects of CDK8/19 inhibitors on arginase-1 expression in macrophages have not yet been elucidated. This study investigated the effects of CDK8/19 inhibitor on arginase-1 expression in IL-4-activated macrophages. The results showed that BRD6989 increased arginase-1 expression transcriptionally in murine peritoneal macrophages and the murine macrophage cell line RAW264.7 in an IL-4-dependent manner. In addition, the results indicated that BRD6989 enhances signal transducer and activator of transcription (STAT) 6 phosphorylation. Meanwhile, BRD6989 exhibited the capability to activate p38 mitogen-activated protein kinase (MAPK) even in the absence of IL-4 stimulation. Moreover, we observed that a p38 MAPK inhibitor suppressed the BRD6989-induced increase in arginase-1 expression. Besides, BRD6989 increased the surface expression of CD206, an M2 macrophage marker. Thus, this study demonstrated for the first time that CDK8/19 inhibition increases arginase-1 expression, suggesting that this mechanism involves the activation of STAT6 and p38 MAPK. This finding implies that CDK8/19 inhibition may facilitate the production of anti-inflammatory M2 macrophages.
摘要:
巨噬细胞通过白细胞介素(IL)-4极化成交替激活的M2巨噬细胞,它们表达高水平的精氨酸酶-1,从而促进抗炎反应。一些研究证实了细胞周期蛋白依赖性激酶(CDK)8/19抑制的抗炎作用,因此,许多CDK8/19抑制剂,如BRD6989,已开发。然而,CDK8/19抑制剂对巨噬细胞精氨酸酶-1表达的影响尚未阐明.这项研究调查了CDK8/19抑制剂对IL-4激活的巨噬细胞中精氨酸酶-1表达的影响。结果表明,BRD6989以IL-4依赖性方式在小鼠腹膜巨噬细胞和小鼠巨噬细胞系RAW264.7中转录增加精氨酸酶-1的表达。此外,结果表明,BRD6989增强了信号转导和转录激活因子(STAT)6的磷酸化。同时,BRD6989即使在没有IL-4刺激的情况下也显示出激活p38丝裂原活化蛋白激酶(MAPK)的能力。此外,我们观察到p38MAPK抑制剂抑制了BRD6989诱导的精氨酸酶-1表达的增加。此外,BRD6989增加了M2巨噬细胞标记物CD206的表面表达。因此,这项研究首次证明了CDK8/19抑制增加了精氨酸酶-1的表达,提示该机制涉及STAT6和p38MAPK的激活。该发现暗示CDK8/19抑制可以促进抗炎M2巨噬细胞的产生。
公众号